Affordable Continuous Glucose Monitoring with Dexcom's Stelo Device
Transformative Innovation in Diabetes Management
Affordable continuous glucose monitoring is evolving, with the FDA's recent approval of Dexcom's Stelo device. This innovative technology is the first over-the-counter (OTC) continuous glucose monitor (CGM), empowering patients with Type 2 diabetes.
Key Features of the Dexcom Stelo Device
- Easily accessible monitoring
- Real-time glucose tracking
- Designed for simple at-home use
Continuous glucose monitoring with the Stelo device enables patients to manage their health effectively, leading to better outcomes in diabetes care. This change in technology signifies a pivotal moment for Type 2 diabetes patients seeking affordability in their health solutions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.